Likarda, a leading biotech company specializing in the development of enabling technologies for the delivery of both cell therapies and large molecule biologics, announced a new grant from the Gates ...

Clonal colonies of transfected CHO, HEK293 or myeloma cells secreting a recombinant protein of interest are probed in situ with target protein–specific, fluorophore-conjugated antibody ...

A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in older adults.

As scientists push the limits of antibody therapeutics, they require rapid, automated workflows for screening, isolating, and assaying antibody-secreting cells. New technology allows researchers to ...

Researchers at Vaxart Inc. and the Center for Vaccine Development at the University of Maryland School of Medicine evaluated ...

The study also simulates an AbD workflow, using Cyto-Mine ® Chroma to precisely isolate rare cells secreting antigen-specific antibodies. Utilizing a viability dye alongside IgG-specific probes ...

4 By coating the inside of the bowl-shaped nanovials with antibodies that are specific to proteins released by a cell of interest, the researchers could capture individual cells and quantify their ...

Cells were identified and isolated based on productivity (IgG secretion) and antigen specificity (antibody-antigen binding) while maintaining high accuracy. In alignment with AbD workflows ...

Abbreviations: APRIL = a proliferation-inducing ligand; ASC = antibody-secreting cell; B = B cell; BAFF = B-cell-activating factor; BAFF-R = B-cell-activating factor receptor; BCMA = B-cell ...

Vaxart (VXRT) announced that complete data from the Phase 1b trial of its first-generation oral pill norovirus vaccine candidate in elderly ...